Apr 25, 2016· Comment from ACT | The App Association· FDA-2015-D-5105-0047
Please see attached for the views of ACT | The App Association regarding the Food and Drug Administration's draft guidance on managing postmarket cybersecurity vulnerabilities for marketed medical devices. I urge you to contact the undersigned with any questions, concerns, or ways that ACT | The App Association can be of assistance. Best regards, Brian Scarpelli Senior Policy Counsel 517-507-1446 | bscarpelli@actonline.org ACT | The App Association